PATHOZONE 250 mg, intramamarna suspenzija, za krave u laktaciji
PATHOZONE 250 mg, intramamarna suspenzija, za krave u laktaciji
Authorised
- Cefoperazone sodium
Product identification
Medicine name:
PATHOZONE 250 mg, intramamarna suspenzija, za krave u laktaciji
Active substance:
- Cefoperazone sodium
Target species:
-
Cattle (lactating cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cefoperazone sodium258.90/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle (lactating cow)
-
Meat and offal0day
-
Milk3dayMlijeko liječenih krava nije prikladno za hranu ljudi i životinja tijekom liječenja te 72 sata nakon zadnje primjene, tj. 6 mužnji ako se krave muzu 2 puta na dan.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51DD12
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Croatia
Available in:
-
Croatia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Haupt Pharma Latina S.r.l.
Responsible authority:
- Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
- UP/I-322-05/13-01/319
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Croatian (PDF)
Published on: 18/02/2022
